We are live on ! Find out more
Cliff Asness

Cliff Asness AQR Capital Management

AUM $337B Turnover 9.09%
1-Year Est. Return 36.06%
 

Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.

This Fund
S&P 500
This Quarter Est. Return
+4.02%
1 Year Est. Return
+36.06%
3 Year Est. Return
+133.13%
5 Year Est. Return
+158.29%
10 Year Est. Return
+535.66%
AUM
$337B
AUM Growth
+$50.6B
Cap. Flow
+$49.6B
Cap. Flow %
14.7%
Top 10 Hldgs %
12.99%
Holding
4,168
New
268
Increased
2,264
Reduced
1,408
Closed
111
Avg Time Held
4.2 years
Top 10 Avg Time Held
3.5 years
Top 20 Avg Time Held
2.4 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.43B
2
AMZN icon
Amazon
AMZN
+$1.19B
3
ORCL icon
Oracle
ORCL
+$1.12B
4
AAPL icon
Apple
AAPL
+$1.07B
5
META icon
Meta Platforms (Facebook)
META
+$977M

Top Sells

Rank Stock Value
1
EIX icon
Edison International
EIX
+$578M
2
PCG icon
PG&E
PCG
+$463M
3
AON icon
Aon
AON
+$369M
4
PEP icon
PepsiCo
PEP
+$368M
5
SNOW icon
Snowflake
SNOW
+$357M

Sector Composition

Rank Sector Weight
1 Technology 27.56%
2 Financials 13.86%
3 Industrials 12.71%
4 Healthcare 11.04%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UP icon
4001
Wheels Up
UP
$81.9M
$79.8K ﹤0.01%
+24,793
New +$132K
2026 Q3
0 quarters
TTEC icon
4002
TTEC Holdings
TTEC
$152M
$75.5K ﹤0.01%
58,072
-576,993
-91% -$1.02M
2013 Q2
53 quarters
OBIO icon
4003
Orchestra BioMed
OBIO
$560M
$73.2K ﹤0.01%
+11,776
New +$56.5K
2026 Q3
0 quarters
LODE icon
4004
Comstock
LODE
$103M
$71.7K ﹤0.01%
+30,914
New +$102K
2026 Q3
0 quarters
IAUX icon
4005
i-80 Gold
IAUX
$1.05B
$68.4K ﹤0.01%
41,209
-48,455
-54% -$77.2K
2026 Q1
2 quarters
ARAI icon
4006
Arrive AI
ARAI
$2.85M
$68.1K ﹤0.01%
6,535
-11,428
-64% -$151K
2026 Q1
2 quarters
TUSK icon
4007
Mammoth Energy Services
TUSK
$151M
$67.2K ﹤0.01%
23,676
-154,148
-87% -$463K
2025 Q3
4 quarters
EAD icon
4008
Allspring Income Opportunities Fund
EAD
$352M
$67.1K ﹤0.01%
11,162
– –
2026 Q2
1 quarter
SKIN icon
4009
SkinHealth Systems
SKIN
$98.1M
$65.8K ﹤0.01%
5,221
-18,974
-78% -$272K
2025 Q1
6 quarters
CRDF icon
4010
Cardiff Oncology
CRDF
$65.9M
$64.6K ﹤0.01%
53,376
-292,977
-85% -$314K
2026 Q1
2 quarters
PRME icon
4011
Prime Medicine
PRME
$932M
$63.8K ﹤0.01%
20,885
-97,113
-82% -$323K
2024 Q4
7 quarters
CRMT icon
4012
America's Car Mart
CRMT
$7.75M
$61.4K ﹤0.01%
60,212
-226,993
-79% -$608K
2025 Q4
3 quarters
BOOM icon
4013
DMC Global
BOOM
$152M
$59.3K ﹤0.01%
10,628
-72,246
-87% -$475K
2025 Q1
6 quarters
HUMA icon
4014
Humacyte
HUMA
$150M
$59K ﹤0.01%
114,051
-2,483,083
-96% -$1.59M
2023 Q4
11 quarters
FLYX icon
4015
flyExclusive
FLYX
$52.6M
$55K ﹤0.01%
45,071
-22,330
-33% -$28.8K
2026 Q1
2 quarters
ZURA icon
4016
Zura Bio
ZURA
$104M
$52.7K ﹤0.01%
+12,663
New +$67.6K
2026 Q3
0 quarters
CURI icon
4017
CuriosityStream
CURI
$190M
$51.8K ﹤0.01%
17,788
-202,021
-92% -$556K
2025 Q3
4 quarters
WHWK icon
4018
Whitehawk Therapeutics
WHWK
$178M
$50.9K ﹤0.01%
+13,543
New +$57.1K
2026 Q3
0 quarters
SLDP icon
4019
Solid Power
SLDP
$371M
$50.9K ﹤0.01%
21,420
-24,048
-53% -$56.4K
2025 Q1
6 quarters
STIM icon
4020
Neuronetics
STIM
$121M
$48.3K ﹤0.01%
20,637
-97,185
-82% -$239K
2026 Q1
2 quarters
ISPR icon
4021
Ispire Technology
ISPR
$87.8M
$48.1K ﹤0.01%
37,562
-68,334
-65% -$102K
2025 Q2
5 quarters
LAB icon
4022
Standard BioTools
LAB
$245M
$46.3K ﹤0.01%
62,476
-1,296,542
-95% -$996K
2024 Q1
10 quarters
BTMD icon
4023
Biote
BTMD
$26M
$46K ﹤0.01%
37,976
-213,643
-85% -$377K
2025 Q1
6 quarters
EOSE icon
4024
Eos Energy Enterprises
EOSE
$626M
$43.4K ﹤0.01%
14,169
-104,065
-88% -$405K
2025 Q3
4 quarters
MVIS icon
4025
Microvision
MVIS
$35.1M
$41.8K ﹤0.01%
27,873
-34,819
-56% -$106K
2026 Q1
2 quarters

Similar funds

Cliff Asness's Q3 2026 Portfolio in Review

As of Q3 2026, Cliff Asness held 4,168 positions worth $337B, up 18% from $287B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Cliff Asness deployed $49.6B of net new capital in Q3 2026, opening 268 new positions and adding to 2,264 existing holdings. Its largest new stake was SpaceX: 482,793 shares worth $72.8M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Edison International, an estimated $578M trimmed.

  • Cliff Asness's largest Q3 2026 buy was SpaceX: 482,793 shares worth $72.8M.
  • Cliff Asness added most to NVIDIA in Q3 2026, an estimated $1.43B increase.
  • Cliff Asness's biggest Q3 2026 reduction was Edison International, cutting an estimated $578M.
  • Cliff Asness fully exited Janus Henderson in Q3 2026, selling an estimated $170M.
  • Cliff Asness's ten largest holdings make up 13% of its $337B portfolio in Q3 2026.
  • Cliff Asness opened 268 new positions and closed 111 in Q3 2026.
  • Cliff Asness's portfolio value rose 18% quarter-over-quarter to $337B.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.